Truist Reiterates Buy Rating on Astrana Health, Inc (ASTH) Following Conference Call

March 3, 2025 10:33 AM

Truist Securities analyst Jailendra Singh reiterated a Buy rating and $50.00 price target on Astrana Health, Inc (NASDAQ: ASTH).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found